Navigation Links
Duragesic Trials Continue - Plaintiffs Optimistic After Latest Recall
Date:2/13/2008

Lawyer who brought the first federal case against J&J prepares for next

trial

LOS ANGELES, Feb. 13 /PRNewswire/ -- In the wake of Tuesday's Duragesic recall of over 2 million patches, lawyer Ike Gulas prepares to take the next major case against pharmaceutical giant Johnson and Johnson to trial in California State Court Southeast District in Los Angeles.

The Birmingham, Ala.-based law firm Gulas & Stuckey PC took the first Duragesic case to federal trial in West Palm Beach in June 2007, winning a $5.5 million verdict for the family of Adam Hendelson who died from an overdose of the drug fentanyl when the patch he wore due to chronic hip pain leaked.

The family of Carol Pinedo will be the second of Gulas & Stuckey's clients to face Johnson & Johnson subsidiaries Janssen Pharmaceutica Products, LP, and ALZA Corp. in court over death resulting from the company's pain patch Duragesic.

Pinedo died in April 2004, the same month Janssen issued a recall of about 2.2 million patches after determining that some might leak along one edge. She was 39 at the time and had been wearing a Duragesic patch for 6 months as treatment for severe migraines following the removal of benign brain tumors.

Pinedo's husband Joseph, has brought the suit forward to Gulas & Stuckey after his wife's death. Joseph is a custodian for the Los Angeles school system with four children: Jessie Marie, Michelle, Christine and Natalie Angela.

"The manufacturers of this drug should be held accountable," said Ike Gulas. "This recent recall reaffirms the fact that this drug is lethal and is responsible for many unnecessary deaths, as in the case of Carol Pinedo."

More than 100 cases have been filed nationwide involving Duragesic. Gulas & Stuckey will take the Pinedo case to trial sometime later this year.

For more information about Duragesic and about Gulas & Stuckey, P.C., go to http://www.gulasandstuckey.com/PracticeAreas/duragesic.asp.


'/>"/>
SOURCE Gulas & Stuckey, P.C.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. PriCara(TM) Recalls 25 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches
2. Study Questions Dead-End Cancer Clinical Trials
3. Clinical trials present better alternatives for dialysis patients
4. IMPACT initiative looks to improve patient participation in clinical trials
5. Clinical Trials Directive still hampering academic medical research
6. Oncolytics Biotech Inc. reports positive interim results of UK phase Ia/Ib trials
7. American Pacific Management to Present at CIBC World Markets 2nd Industrials Conference
8. Clinical Trials for Lupus Underway After Decades of Drought
9. Paving the way for future pan-European clinical trials
10. GenPrime Initiates External Clinical Trials of its Bacterial Contamination Test for Rapid Detection of Bacteria in Platelets
11. Rutgers biomaterial debuts in clinical trials of new stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ProVest Insurance Group, ... Dallas, Miami, and Raleigh regions, is organizing an extended charity drive to benefit ... deadly chromosome abnormality. , After struggling since birth with several health challenges, T.J. ...
(Date:10/13/2017)... ... October 13, 2017 , ... The International ... promote standards of excellence for the field of eating disorders, announces the opening ... 25, 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term ... long-term care insurance companies have a waiver for care if the client has a ... when the family pays for care, is often waived, so the benefits from their ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented ... the lowdown on sciatica in a new episode of "Success Files," which is ... events and innovation and investigates each subject in-depth with passion and integrity. , ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017 Diplomat Pharmacy, ... 8th Day Software and Consulting, LLC , and named ... 8th Day Software, based in Tennessee , ... 8th Day expands EnvoyHealth,s service offerings for health care ... "In an interoperable ...
(Date:10/2/2017)... Oct. 2, 2017 Halo Labs announces the European launch ... called the HORIZON at MIBio 2017 in Cambridge, U.K ... visible particulate matter in biopharmaceutical samples with unprecedented speed and sensitivity ... novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans Bioscience ... the use of wearable and home sensors for real-time ... Early Signal Foundation, a nonprofit organization focused on disruptive ... provide an affordable analytical system to record and integrate ... ...
Breaking Medicine Technology: